HIT Consultant January 17, 2025
What You Should Know:
– Mayo Clinic is expanding its collaboration with SandboxAQ, a provider of artificial intelligence (AI) medical apps to explore the use of electrocardiography (ECG) and magnetocardiography (MCG) technologies for characterizing disease progression and treatment response in patients with amyloidosis.
– The expanded partnership highlights the potential of combining AI and advanced sensing technology to revolutionize cardiac diagnostics.
Improved Detection and Monitoring of Amyloidosis and Other Cardiac Conditions
Amyloidosis is a condition characterized by the buildup of abnormal protein deposits in organs and tissues, including the heart. Early diagnosis and accurate monitoring are crucial for effective management, but current tools often fall short in detecting subtle changes in cardiac function.
The expanded collaboration aims to address this...
Today's Sponsors
Today's Sponsor